Monoclonal Antibodies and Viral Recombinant Tender in USA - 115815450

Procurement Summary

Country: USA

Summary: Monoclonal Antibodies and Viral Recombinant Antigens

Deadline: 20 Mar 2025

Posting Date: 06 Mar 2025

Other Information

Notice Type: Tender

TOT Ref.No.: 115815450

Document Ref. No.:

Competition: ICB

Financier: Self Financed

Purchaser Ownership: Public

Tender Value: Refer Document

Purchaser's Detail

Name: Login to see tender_details

Address: Login to see tender_details

Email: Login to see tender_details

Login to see details

Tender Details

Description
The U.S. Army Medical Research Acquisition Activity (USAMRAA) intends to award a Firm Fixed Price, sole sourceContract on behalf of the United States Army Medical Research Institute of Infectious Diseases (USAMRIID) to MappBiopharmaceutical, Inc.located in San Diego, CA 92121, under the authority as prescribed in FAR 13.105(a)(1)(ii) sole source (including brand name) under the authority of simplified procedures for certain commercial items. This materiel requirement is for the delivery of human-derived monoclonal antibodies (mAbs) and viral recombinant antigens (Ags) from Mapp Biopharmaceutical, Inc. library. These products have been developed from previously funded efforts with Mapp Biopharmaceutical, Inc. andUSAMRIID. This Notice of Intent is NOT a request for quotations (RFQ) and no solicitation document exists for the requirement; however, if a vendor challenges the basis for this requirement, please submit a capability statement that includes sufficient detail and with convincing evidence that clearly demonstrates the capability to provide these services. A determination by the Government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the Government. A request for documentation or additional information or submissions that only ask questions will not be considered as an affirmative response. A determination by the Government not to compete based on responses to this notice is solely within the discretion of the Government. Information received will be considered solely for the purpose of determining whether to conduct a competitiveprocurement or to proceed with a sole source procurement.Capability statements are due no later than 1000 Eastern Time, 20 March 2025. Capability statements shall be submitted via email ONLY as a Microsoft Word or Adobe PDF attachment to the following email address [email protected]. No phone calls will be accepted.
Active Contract Opportunity

Notice ID :

Related Notice

Department/Ind. Agency : DEPT OF DEFENSE

Sub-tier : DEFENSE HEALTH AGENCY (DHA)

Office: ARMY MED RES ACQ ACTIVITY

General Information

Contract Opportunity Type: Special Notice (Original)

Original Published Date: Mar 05, 2025 03:13 pm EST

Original Response Date: Mar 20, 2025 01:00 pm EDT

Inactive Policy: 15 days after response date

Original Inactive Date: Apr 04, 2025

Initiative: None
Classification

Original Set Aside:

Product Service Code: 6550 - IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS

NAICS Code:

Place of Performance: MD USA

Documents

 Tender Notice

A02-JA_Redacted_03.pdf